Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Implant may prevent spread of cancer
Microscope
Scientists are planning the first clinical trials in humans very soon.
Device sucks up cancer cells as they move through the body

A tiny implant that sucks up cancer cells as they move through the body has been developed by scientists in the USA.

Although the device has only been tested in mice with breast cancer, scientists hope that it may one day alert doctors to the spread of cancer, acting as an early warning system for human patients.

The findings, published in Nature Communications, show that the implant could also prevent rogue cancer cells reaching other areas where new tumours could develop.

The device is around 5mm in diameter and is made of a sponge-like material that is already approved for use in medicine.

Experiments showed that if the device was planted under the skin or in the abdominal fat, it would mop up the cancer cells that had begun to move around the body.

Study leader Professor Lonnie Shea, from the Department of Biomedical Engineering at the University of Michigan, told the BBC that they were planning the first clinical trials in humans fairly soon.

"We need to see if metastatic cells will show up in the implant in humans like they did in the mice, and also if it's a safe procedure and that we can use the same imaging to detect cancer cells," he said.

Cancer Research say that nine out of 10 cancer deaths are caused by the spread of the disease to other parts of the body.

Lucy Holmes, Cancer Research UK's science information manager, added: "We urgently need new ways to stop cancer in its tracks.

"So far this implant approach has only been tested in mice, but it's encouraging to see these results, which could one day play a role in stopping cancer spread in patients."

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.